In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an antioxidant compound investigated for application in neurodegenerative diseases.
OcuTerra’s diabetic retinopathy drug fails PhII; Better Therapeutics to shut down
Plus, news about Immuneering, Aditum Bio, Unicycive and X-Therma: OcuTerra Therapeutics’ diabetic retinopathy drug fails PhII: The company’s RGD integrin inhibitor did not meet the